Diamedica Therapeutics Inc (DMAC)

Jun 12, 2026

DiaMedica Therapeutics (DMAC) Gains 3.66% as Biotech Stock Tests Key Resistance ZonePut Spread Alert - newsline.com

Jun 12, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) director granted 40,412 stock options at $5.84 - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica (DMAC) director Richard Kuntz receives grant of 40,412 stock options - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) director granted 40,412-share stock option award - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica (DMAC) director Tanya Lewis awarded 40,412 stock options at $5.84 - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) director receives 40,412-share stock option grant - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (NASDAQ: DMAC) director receives grant of 51,189 stock options - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) CEO awarded 380,000 stock options - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) CFO awarded 162,000 stock options at $5.84 strike - Stock Titan

Jun 03, 2026

Jun 03, 2026

DiaMedica Therapeutics (DMAC) CMO receives 67,500 stock options expiring 2036 - Stock Titan

Jun 03, 2026

Jun 02, 2026

DiaMedica Shares Down Ahead of Stroke Trial Update - Bez Kabli

Jun 02, 2026

Jun 01, 2026

DiaMedica (DMAC) Q4 2025 Earnings Transcript - The Globe and Mail

Jun 01, 2026

May 29, 2026

DiaMedica Therapeutics (DMAC) Slides 2.76% as Biotech Sector Headwinds Pressure Small-Cap NamesWave Equality - The Legal Advocate

May 29, 2026

May 28, 2026

DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026 - BioSpace

May 28, 2026

May 27, 2026

DMAC Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Pipeline AdvancesProfit Guidance Range - The Legal Advocate

May 27, 2026

May 26, 2026

DiaMedica Therapeutics (DMAC) Gains 4% as Stock Approaches Key Resistance LevelCumulative Volume - The Legal Advocate

May 26, 2026

May 25, 2026

DiaMedica Therapeutics (DMAC) Gains 2.43% as Buyers Defend Key SupportSynthetic Long - The Legal Advocate

May 25, 2026

May 22, 2026

DiaMedica Shareholders Approve Governance, Compensation and Incentive Plan - The Globe and Mail

May 22, 2026

May 22, 2026

DMAC Q1 2026 Earnings: Wider Loss Than Expected as Clinical Pipeline AdvancesFinancial Health Score - thelegaladvocate.com

May 22, 2026

May 21, 2026

DiaMedica Therapeutics (NASDAQ: DMAC) investors approve directors, pay and 3.5M-share incentive plan boost - Stock Titan

May 21, 2026

May 20, 2026

DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial - BioSpace

May 20, 2026

May 20, 2026

DiaMedica stroke trial reaches 75% of interim analysis threshold By Investing.com - Investing.com South Africa

May 20, 2026

May 20, 2026

DiaMedica stroke trial reaches 75% of interim analysis threshold - Investing.com India

May 20, 2026

May 20, 2026

DiaMedica Therapeutics (DMAC) Advances in Pivotal Trial Enrollme - GuruFocus

May 20, 2026

May 20, 2026

DiaMedica Therapeutics Says Trial of DM199 to Treat Acute Ischemic Stroke Reaches 75% Enrollment - marketscreener.com

May 20, 2026

May 20, 2026

Diamedica Therapeutics announces 75% enrollment milestone in Remedy2 phase 2/3 acute ischemic stroke trial - marketscreener.com

May 20, 2026

May 19, 2026

Why Is DiaMedica Therapeutics Inc. (DMAC) Stock Down Today? - Meyka

May 19, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 13, 2026

DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference - BioSpace

May 13, 2026

May 10, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

May 10, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 09, 2026

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2026 Earnings Call Transcript - insidermonkey.com

May 09, 2026

May 09, 2026

DiaMedica (DMAC) Q1 2026 Earnings Transcript - AOL.com

May 09, 2026

May 08, 2026

Why DiaMedica (DMAC) deserves a deeper look right now (Bearish Sentiment) 2026-05-08Social Investment Platform - newser.com

May 08, 2026

May 08, 2026

DiaMedica Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2026

May 07, 2026

Transcript : DiaMedica Therapeutics Inc., Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Q1 Earnings Call Highlights - Barchart.com

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Inc. Q1 2026 Financial Results, Clinical Trial Updates, and Forward-Looking Statements - Minichart

May 07, 2026

May 07, 2026

Earnings call transcript: DiaMedica Therapeutics Q1 2026 results show R&D focus - Investing.com

May 07, 2026

May 07, 2026

DMAC: DM199 trials progress in preeclampsia and stroke, with strong cash position and key data ahead - TradingView

May 07, 2026

May 07, 2026

Diamedica Therapeutics Inc. (DMAC) Files Form 8-K with Financial Statements and Company Information for May 2026 - Minichart

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights - BioSpace

May 07, 2026

May 06, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience - ChartMill

May 06, 2026

May 06, 2026

[10-Q] DiaMedica Therapeutics Inc. Quarterly Earnings Report - Stock Titan

May 06, 2026

May 06, 2026

DiaMedica Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 06, 2026

May 06, 2026

Higher R&D drives DiaMedica (NASDAQ: DMAC) wider Q1 2026 loss - Stock Titan

May 06, 2026